India to Ecuador: Mycophenolate Export Trade Route
India has recorded 3 verified shipments of Mycophenolate exported to Ecuador, representing a combined trade value of $2.6M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $862.2K USD. The leading Indian exporter is PANACEA BIOTEC PHARMA LIMITED, which accounts for 98% of total export value with 1 shipments worth $2.5M USD. On the buying side, BANCO BOLIVARIANO C.A. is the largest importer in Ecuador with $2.5M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Ecuador Mycophenolate corridor is one of India's established pharmaceutical export routes, with 3 shipments documented worth a combined $2.6M USD. The route is dominated by PANACEA BIOTEC PHARMA LIMITED, which alone accounts for roughly 98% of all export value, reflecting the consolidated nature of India's mycophenolate manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $862.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (33.33%) and air (66.67%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April-June, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 33.1%, placing it at rank #15 among India's top mycophenolate export destinations globally.
On the import side, key buyers of Indian mycophenolate in Ecuador include BANCO BOLIVARIANO C.A., F.D.E.C.A. BANCO BOLIVARIANO C.A. is the single largest importer with 1 shipments valued at $2.5M USD.
